1. Kanner A.M. Depression in neurological disorders. 2005. Lundbec Institute. 160p.
2. Murray C.J.L., Lopez A.D. (eds.). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health 1996.
3. Вейн А.М., Вознесенская Т.Г. и др. Депрессия в неврологической практике. МИА 2007. 197 с.
4. Frodl et al. Am. J. Psych. 2002; McKittrick et al. Synapse. 2000;
5. Duman R. CNS Spectrum. 2002.
6. Воробьева О.В. Клинические особенности депрессии в общемедицинской практике (по результатам программы «Компас») // Consilium Medicum. 2004; 6 (2). С. 154-15.
7. Руководство по первичной медико-санитарной помощи. А.А. Баранов, Денисов И.Н., Чучалин А.Г. Издатель. ГЭОТАР-Медиа, 2006. ISBN.
8. Jacob R.G., Lilienfeld S.O. Panic disorder, diagnosis, medical assessment and psychological assessment. In: Walker I.R., Norton G.R., Ross C. A. (eds) Panic Disorder and Agorafobia. Belmont 1991; part 3; 433-69.
9. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Julian P.T., Higgin J.P.T., Churchil R., Watanabe N., Nakagawa A., Omori I.M., McGuire H., Tansella M., Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis // Lancet. 2009; 373: 746-758.
10. Sheikh J.I., Cassidy E.L., Doraiswamy P.M., et al. Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comor-bid medical illness. - J. Am. Geriatr. Soc. - 2004. - Vol. 52. - P. 86-92.
11. Thorlund K., Druyts E., Wu P., et al. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepineph-rine reuptake inhibitors in older adults: a network meta-analysis. - J. Am. Geriatr. Soc. - 2015. - Vol. 63. - P. 1002-1009.
12. Xiong G.L., Fiuzat M., Kuchibhatla M., et al. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. - Circ. Heart Fail. - 2012. - Vol. 5. - P. 688-692.
13. Serebruany V.L., Glassman A.H., Malinin A.I. et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy. - Circul. - 2003. - Vol. 108. - P. 939-944.
14. Murray V., von Arbin M., Bartfai A., Berggren A.L., et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J. Clin. Psychiatry. 2005 Jun; 66 (6): 708-16.
15. Костенко Е.В., Энеева М.Е., Бобырeва С.Н. Антидепрессанты в комплексной терапии депрессивных расстройств и нарушений сна в постинсультном периоде. Медицинский алфавит. 2015, т. 2, № 19 с.
16. Pollack M.H., Marzol P.C. Panic: course, complications and treatment of panic disorder. J Psychopharmacol. 2000; 14 (2 Suppl 1): S 25-30.
17. Gustaw K. Myofascial pain syndrome in farmers - a comprehensive approach to treatment. Ann. Agric. Enviro.n Med. 2000; 7 (2): 95-9.
18. Engel C.C. Jr., Walker E.A., Engel A.L., Bullis J., Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J. Psychosom. Res. 1998 Feb; 44 (2): 203-7.
19. Goodnick P.J., Jimenez I., Kumar A. Sertraline in diabetic neuropathy: preliminary results. Ann. Clin. Psychiatry. 1997 Dec; 9 (4): 255-7.
20. McMahon C.G., Samali R. Pharmacological treatment of premature ejaculation. Curr. Opin. Urol. 1999 Nov; 9 (6): 553-61.
21. Дюкова Г.М., Сметник В.П., Назарова Н.А. 2001. Состояние психовегетативной и сексуальной сфер у женщин в перименопаузе. Руководство по климаксу: Руководство для врачей. Под. ред. В.И. Кулакова, В.П. Сметник. М., МИА: 361-380.
Послать статью по эл. почте 